Advanced Solid Tumors With MAPK Pathway Mutations
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors With MAPK Pathway Mutations
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations (NCT05886920) | D3 Bio (Wuxi) Co., Ltd | 2023-07-10 |
Track Advanced Solid Tumors With MAPK Pathway Mutations automatically
Every clearance here is in the API, with alerts when new ones post.